Summit Therapeutics operates as a clinical-stage biopharmaceutical enterprise focused heavily on researching, developing, and commercializing novel oncology medicines and advanced therapeutic drug candidates. Because its primary pipeline products remain in clinical trial phases rather than broad commercial distribution, the corporation generates minimal product sales revenue, relying instead on collaborative licensing agreements, upfront partnership payments, and financial backing to fund operations.